Skip to content

Merchavia

  • HOME
  • COMPANY PROFILE
  • LIFE SCIENCE INVESMENTS
  • MEDICAL DISTRIBUTION
  • INVESTOR RELATIONS
  • MEDIA
  • CONTACT
  • HOME
  • COMPANY PROFILE
  • LIFE SCIENCE INVESMENTS
  • MEDICAL DISTRIBUTION
  • INVESTOR RELATIONS
  • MEDIA
  • CONTACT
Read more about the article Receiving additional consideration for a merger transaction between Remedy (9%) with Optimize
RMDY

Receiving additional consideration for a merger transaction between Remedy (9%) with Optimize

  • Post published:26/08/2020
Read more about the article Results of general meeting
pdf1

Results of general meeting

  • Post published:20/08/2020
Read more about the article Invest $ 100 in a fundraising round at E.F.A, hold after 8.15%
MERCHAVIA

Invest $ 100 in a fundraising round at E.F.A, hold after 8.15%

  • Post published:16/08/2020
Read more about the article Merchavia invest in Aura Smart Air, a company that deals with purification and air quality management using artificial intelligence technology
picture image

Merchavia invest in Aura Smart Air, a company that deals with purification and air quality management using artificial intelligence technology

  • Post published:05/08/2020
Read more about the article Cardiacsense (5.67%) received a medical certificate for medical clock for heart rate monitoring and diagnosis of atrial fibrillation
CARDIACSENSE

Cardiacsense (5.67%) received a medical certificate for medical clock for heart rate monitoring and diagnosis of atrial fibrillation

  • Post published:02/08/2020
Read more about the article Memorandum of Understanding for the investment of $ 250,000 in Ora Air (engaged in air quality), against 1.93% in Ora Air
pdf1

Memorandum of Understanding for the investment of $ 250,000 in Ora Air (engaged in air quality), against 1.93% in Ora Air

  • Post published:29/07/2020
Read more about the article Calling of special meeting of Aug 20, 2020
merchavia icon

Calling of special meeting of Aug 20, 2020

  • Post published:15/07/2020
Read more about the article Continues to negotiate a binding agreement for a business partnership with CD’X
CDX

Continues to negotiate a binding agreement for a business partnership with CD’X

  • Post published:12/07/2020
Read more about the article CD’X (held 7%) began commercial-marketing OISPSA test for the Cleveland Clinic Urology Department
CDX

CD’X (held 7%) began commercial-marketing OISPSA test for the Cleveland Clinic Urology Department

  • Post published:08/07/2020
Read more about the article Cardiacsense (approx. 5.87%) – Starting an Experiment on the Smart Watch for Breathing Rhythm at Ichilov Hospital
CARDIACSENSE

Cardiacsense (approx. 5.87%) – Starting an Experiment on the Smart Watch for Breathing Rhythm at Ichilov Hospital

  • Post published:21/06/2020
← Newer Posts
Older Posts →

Investor Relations

  • Investors Lobby
  • Company Profile
  • Company Presentation
  • Immediate Reports
  • Financial Reports
  • Investors News
  • News in the Media
  • Management
  • Stock Chart
  • FAQ
  • Mail Alert
  • Contact

© all rights preserve to Merchavia LTD

HOME
COMPANY PROFILE
LIFE SCIENCE INVESMENTS
INVESTOR RELATIONS
Accessibility
CONTACT